TY - JOUR
T1 - Human papillomavirus
T2 - Molecular biology and screening applications in cervical neoplasia - A primer for primary care physicians
AU - Bristow, Robert E.
AU - Montz, F. J.
PY - 1998
Y1 - 1998
N2 - In recent years, much insight has been gained into the molecular pathogenesis of cervical cancer and its precursor lesions. Specific types of human papillomavirus (HPV) are the principle etiologic agents in cervical neoplasia. Interactions between HPV and cell-derived proteins result in deregulation of cell cycle progression an d appear to be critical for the development of cervical cancer. HPV DNA testing may have limited clinical utility as a primary screening tool in underdeveloped countries or underserved populations where access to repeated, reliable cytologic screening is severely limited or in which the prevalence of cervical cancer and precursor lesions is high. In areas where cervical cytologic screening is well established and the incidence of clinically significant pre-invasive disease is not excessive, HPV typing is of unproven benefit as a primary screening tool. In selected settings, triaging women with a minimally abnormal Papanicolaou smear with a combination of repeat cytology and HPV DNA testing appears to be a sensitive alternative to immediate colposcopic evaluation.
AB - In recent years, much insight has been gained into the molecular pathogenesis of cervical cancer and its precursor lesions. Specific types of human papillomavirus (HPV) are the principle etiologic agents in cervical neoplasia. Interactions between HPV and cell-derived proteins result in deregulation of cell cycle progression an d appear to be critical for the development of cervical cancer. HPV DNA testing may have limited clinical utility as a primary screening tool in underdeveloped countries or underserved populations where access to repeated, reliable cytologic screening is severely limited or in which the prevalence of cervical cancer and precursor lesions is high. In areas where cervical cytologic screening is well established and the incidence of clinically significant pre-invasive disease is not excessive, HPV typing is of unproven benefit as a primary screening tool. In selected settings, triaging women with a minimally abnormal Papanicolaou smear with a combination of repeat cytology and HPV DNA testing appears to be a sensitive alternative to immediate colposcopic evaluation.
UR - http://www.scopus.com/inward/record.url?scp=0031658649&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0031658649&partnerID=8YFLogxK
U2 - 10.1016/S1068-607X(98)00157-7
DO - 10.1016/S1068-607X(98)00157-7
M3 - Article
AN - SCOPUS:0031658649
SN - 1068-607X
VL - 5
SP - 238
EP - 246
JO - Primary Care Update for Ob/Gyns
JF - Primary Care Update for Ob/Gyns
IS - 5
ER -